ASCO Genitourinary Cancers Symposium
Playback speed
10 seconds
ASCO GU 2022 Survival Outcomes and Characterization of Patients With mCSPC Undergoing Intensified ADT Who Do Not Achieve an Optimal PSA Response
By
ASCO Genitourinary Cancers Symposium
FEATURING
Nicolas Sayegh
By
ASCO Genitourinary Cancers Symposium
FEATURING
Nicolas Sayegh
192 views
February 24, 2022
Login to view comments.
Click here to Login
Videos